BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33631298)

  • 1. Tauroursodeoxycholic acid attenuates cisplatin-induced ototoxicity by inhibiting the accumulation and aggregation of unfolded or misfolded proteins in the endoplasmic reticulum.
    Wen Y; Zong S; Liu T; Du P; Li H; Xiao H
    Toxicology; 2021 Apr; 453():152736. PubMed ID: 33631298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauroursodeoxycholic acid attenuates gentamicin-induced cochlear hair cell death in vitro.
    Jia Z; He Q; Shan C; Li F
    Toxicol Lett; 2018 Sep; 294():20-26. PubMed ID: 29751043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tauroursodeoxycholic acid attenuates cisplatin-induced hearing loss in rats.
    Lee CH; Park SS; Lee DH; Lee SM; Kim MY; Choi BY; Kim SY
    Neurosci Lett; 2020 Mar; 722():134838. PubMed ID: 32061715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic Reticulum Stress Is Involved in Cochlear Cell Apoptosis in a Cisplatin-Induced Ototoxicity Rat Model.
    Zong S; Liu T; Wan F; Chen P; Luo P; Xiao H
    Audiol Neurootol; 2017; 22(3):160-168. PubMed ID: 29049998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity.
    Roldán-Fidalgo A; Martín Saldaña S; Trinidad A; Olmedilla-Alonso B; Rodríguez-Valiente A; García-Berrocal JR; Ramírez-Camacho R
    Exp Toxicol Pathol; 2016 Apr; 68(4):197-204. PubMed ID: 26850526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trehalose protects against cisplatin-induced cochlear hair cell damage by activating TFEB-mediated autophagy.
    Li Z; Yao Q; Tian Y; Jiang Y; Xu M; Wang H; Xiong Y; Fang J; Lu W; Yu D; Shi H
    Biochem Pharmacol; 2022 Mar; 197():114904. PubMed ID: 34971589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SERCA2 protects against cisplatin-induced damage of auditory cells: Possible relation with alleviation of ER stress.
    Xu Y; Zhao H; Wang F; Xu S; Wang C; Li Y; Wang Y; Nong H; Zhang J; Cao Z; Chen C; Li J
    Toxicol Appl Pharmacol; 2024 May; 486():116947. PubMed ID: 38688426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FAM134B-induced endoplasmic reticulum (ER)-phagy exacerbates cisplatin-insulted hair cell apoptosis :Possible relation to excessive ER stress.
    Yang H; Yin H; Wang Y; Liu J; Guo L; Zhao H; Bai X; Li J; Yang Q
    Arch Biochem Biophys; 2023 Oct; 748():109766. PubMed ID: 37813237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, acinar cell damage, and systemic inflammation in acute pancreatitis.
    Seyhun E; Malo A; Schäfer C; Moskaluk CA; Hoffmann RT; Göke B; Kubisch CH
    Am J Physiol Gastrointest Liver Physiol; 2011 Nov; 301(5):G773-82. PubMed ID: 21778463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production.
    Zhang W; Xiong H; Pang J; Su Z; Lai L; Lin H; Jian B; He W; Yang H; Zheng Y
    Toxicol Lett; 2020 Oct; 331():1-10. PubMed ID: 32428544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-lipoic acid protects against cisplatin-induced ototoxicity via the regulation of MAPKs and proinflammatory cytokines.
    Kim J; Cho HJ; Sagong B; Kim SJ; Lee JT; So HS; Lee IK; Kim UK; Lee KY; Choo YS
    Biochem Biophys Res Commun; 2014 Jun; 449(2):183-9. PubMed ID: 24796665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, trypsin activation, and acinar cell apoptosis while increasing secretion in rat pancreatic acini.
    Malo A; Krüger B; Seyhun E; Schäfer C; Hoffmann RT; Göke B; Kubisch CH
    Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G877-86. PubMed ID: 20671193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Tauroursodeoxycholic Acid on Dedifferentiation of Vascular Smooth Muscle Cells by Modulation of Endoplasmic Reticulum Stress and as an Oral Drug Inhibiting In-Stent Restenosis.
    Luo H; Zhou C; Chi J; Pan S; Lin H; Gao F; Ni T; Meng L; Zhang J; Jiang C; Ji Z; Lv H; Guo H
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):25-33. PubMed ID: 30663009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxytyrosol enhances cisplatin-induced ototoxicity: Possible relation to the alteration in the activity of JNK and AIF pathways.
    Zhang W; Man R; Yu X; Yang H; Yang Q; Li J
    Eur J Pharmacol; 2020 Nov; 887():173338. PubMed ID: 32781170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
    Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
    Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-phycocyanin from
    Kim YR; Do JM; Kim KH; Stoica AR; Jo SW; Kim UK; Yoon HS
    Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31010222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
    Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
    J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective GSK-3beta inhibitors attenuate the cisplatin-induced cytotoxicity of auditory cells.
    Park HJ; Kim HJ; Bae GS; Seo SW; Kim DY; Jung WS; Kim MS; Song MY; Kim EK; Kwon KB; Hwang SY; Song HJ; Park CS; Park RK; Chong MS; Park SJ
    Hear Res; 2009 Nov; 257(1-2):53-62. PubMed ID: 19666099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A reduces cisplatin-induced ototoxicity through the STAT6 signaling pathway.
    Huang J; Wang P; Li M; Ge J; Chen J; Chen X
    Int J Mol Med; 2015 Aug; 36(2):493-500. PubMed ID: 26080623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure.
    Vandewynckel YP; Laukens D; Devisscher L; Paridaens A; Bogaerts E; Verhelst X; Van den Bussche A; Raevens S; Van Steenkiste C; Van Troys M; Ampe C; Descamps B; Vanhove C; Govaere O; Geerts A; Van Vlierberghe H
    Oncotarget; 2015 Sep; 6(29):28011-25. PubMed ID: 26293671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.